Ditchcarbon
  • Contact
  1. Organizations
  2. Kedrion
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated 5 hours ago

Kedrion Sustainability Profile

Company website

Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Kedrion's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Kedrion's reported carbon emissions

In 2021, Kedrion S.p.A. reported total carbon emissions of approximately 1,102 kg CO2e, comprising 1,081 kg CO2e from Scope 1 and 21 kg CO2e from Scope 2 emissions. This marked a significant reduction from 2020, where emissions were about 6,600 kg CO2e, with 6,573 kg CO2e from Scope 1 and 27 kg CO2e from Scope 2. The data indicates a trend towards lower emissions, particularly in Scope 1, which saw a decrease of about 5,492 kg CO2e year-on-year. Kedrion has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets through initiatives such as the Science Based Targets initiative (SBTi). The company operates as a current subsidiary of Kedrion Holding Spa, which may influence its climate commitments and reporting practices. Despite the absence of formal reduction targets, Kedrion's emissions data reflects a commitment to improving their carbon footprint. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021
Scope 1
22,062,000
00,000,000
0,000,000
0,000
0,000
Scope 2
-
-
-
00
00
Scope 3
-
-
-
-
-

How Carbon Intensive is Kedrion's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kedrion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Kedrion's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kedrion is in IT, which has a low grid carbon intensity relative to other regions.

Kedrion's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Kedrion has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Kedrion's Emissions with Industry Peers

Biotest

DE
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Harmonic Drive Systems

JP
•
Computer and related services (72)
Updated 3 days ago

HemaCare Corporation

US
•
Health and social work services (85)
Updated about 2 months ago

Emergent BioSolutions

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

KMD

DK
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Grifols

ES
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy